Immunostimulation in recurrent respiratory tract infections therapy in children

W Prusek1, A Jankowski, G Radomska

  • 1Department of Pediatrics, Regional Hospital, Wrocław.

Insights

Immunotherapy effectively treated recurrent respiratory tract infections in children by boosting T cells. Treatments like TFX and Levamisol showed the most positive results, improving immune function.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Recurrent respiratory tract infections (RRTIs) in children are often linked to depressed T lymphocyte counts, similar to conditions seen in AIDS patients.
  • Elevated serum IgM concentrations were also observed in affected children.

Purpose of the Study:

  • To evaluate the effectiveness of various immunotherapies in managing RRTIs in children.
  • To assess changes in immunologic parameters following different treatment modalities.

Main Methods:

  • A study involving 117 children aged 12 months to 10 years with RRTIs.
  • Treatment groups received TFX, Levamisol, Broncho-Vaxom, PADMA, or climatotherapy; a control group received no immunostimulants.
  • Immunologic parameters, including T lymphocyte counts and serum IgM, were monitored.

Main Results:

  • All investigated treatments demonstrated beneficial effects on RRTIs.
  • TFX and Levamisol yielded the highest percentage of positive outcomes.
  • An increase in T cells percentage was observed across all treatment groups, most notably with Levamisol.

Conclusions:

  • Immunotherapies, particularly TFX and Levamisol, are effective in treating RRTIs in children.
  • While T cell percentages increased with treatment, no direct correlation was found between T cell numbers and clinical improvement.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...